Beta-Cells Regenerate Even In Type 1 Diabetes

Previous | Next

This article originally posted 21 June, 2005 and appeared in Issue 265

A new study provides evidence that the pancreas continues to form beta cells even in the setting of long-standing type 1diabetes.

In type 1 diabetes, which by definition indicates a lack of insulin production, the insulin-producing "beta" cells in the pancreas are thought to be wiped out. However, that may not be exactly the case. The results of a new study provide some of the first evidence in humans that the pancreas continues to form beta cells even in the setting of long-standing type 1 diabetes, suggesting a possible new treatment strategy.

Dr. Peter C. Butler from the University of California in Los Angeles told the audience at the ADA Scientific Sessions that, "The implication is that type 1 diabetes could, theoretically, be cured if we could stop the new insulin-secreting cells being destroyed."

Butler presented his team's findings at the American Diabetes Association's annual meeting in San Diego. Type 1 diabetes results when beta cells are mistakenly attacked and destroyed by the body in an autoimmune reaction. Until now, the only hope of reversing the disease seemed to be replacement of beta cells by transplantation. Butler's team has now shown that, among 42 individuals who had type 1 diabetes for decades -- in some cases up to 60 years -- the majority (88 percent) still had detectable insulin-producing beta cells in their pancreas.

"Most interesting," Butler said, "we note that these cells have a high death rate by autoimmune destruction, implying that there must be ongoing new insulin-producing cells being formed. Therefore, type 1 diabetes may be reversible by targeted inhibition of beta cell destruction." A lot more work lies ahead before that becomes possible. "What we do not know yet is what rate these calls are being produced or how they are being produced," Butler said. "These questions are currently being actively addressed in studies by our group, funded by the Juvenile Diabetes Research Foundation."

ADA 57th Scientific Sessions, June 2005

=============================

Obtain your patients’ A1C results when they’re most useful. in2it™ In-Office Analyzer delivers reimbursable, lab-accurate A1C test results when it truly matters—during a patient’s visit. Because its results are unaffected by Hb variants, in2it™ is an easy way to gauge the efficacy of your treatment strategies in less than seven minutes. CLIA waived (cleared for Prescription Home Use, and as a result has been CLIA waived). The in2it™ is available with flexible acquisition options. It’s your opportunity to keep your office’s A1C testing simple. So get the analyzer that makes both clinical and business sense. Get in2it™ For more information: Click Here
http://www.diabetesincontrol.com/in2it/dest.php

==============================

Professional CE- Pharmacists. Need Live CE?? Get 1.5 hours live interactive on the net. June 28th, 2005 1pm. No Charge send an email to rich@pharmacychoice.com to sign up